View in EDS PDF Full Text

Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory NTRK fusion glioblastoma.

Saved in:
Bibliographic Details
Title: Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory NTRK fusion glioblastoma.
Authors: Grogan PT; Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA., Deming DA; Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA., Helgager J; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, USA., Ruszkiewicz T; Department of Human Oncology, University of Wisconsin, Madison, Wisconsin, USA., Baskaya MK; Department of Neurological Surgery, University of Wisconsin, Madison, Wisconsin, USA., Howard SP; Department of Human Oncology, University of Wisconsin, Madison, Wisconsin, USA., Robins HI; Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA.
Source: Neuro-oncology advances [Neurooncol Adv] 2022 Apr 13; Vol. 4 (1), pp. vdac046. Date of Electronic Publication: 2022 Apr 13 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35673607
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory NTRK fusion glioblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Grogan+PT%22">Grogan PT</searchLink>; Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Deming+DA%22">Deming DA</searchLink>; Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Helgager+J%22">Helgager J</searchLink>; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Ruszkiewicz+T%22">Ruszkiewicz T</searchLink>; Department of Human Oncology, University of Wisconsin, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Baskaya+MK%22">Baskaya MK</searchLink>; Department of Neurological Surgery, University of Wisconsin, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Howard+SP%22">Howard SP</searchLink>; Department of Human Oncology, University of Wisconsin, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Robins+HI%22">Robins HI</searchLink>; Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101755003%22">Neuro-oncology advances</searchLink> [Neurooncol Adv] 2022 Apr 13; Vol. 4 (1), pp. vdac046. <i>Date of Electronic Publication: </i>2022 Apr 13 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101755003 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-2498 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226322498%22">26322498 </searchLink><i>NLM ISO Abbreviation: </i>Neurooncol Adv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35673607
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/noajnl/vdac046
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: vdac046
    Titles:
      – TitleFull: Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory NTRK fusion glioblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Grogan PT
      – PersonEntity:
          Name:
            NameFull: Deming DA
      – PersonEntity:
          Name:
            NameFull: Helgager J
      – PersonEntity:
          Name:
            NameFull: Ruszkiewicz T
      – PersonEntity:
          Name:
            NameFull: Baskaya MK
      – PersonEntity:
          Name:
            NameFull: Howard SP
      – PersonEntity:
          Name:
            NameFull: Robins HI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 04
              Text: 2022 Apr 13
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2632-2498
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Neuro-oncology advances
              Type: main
ResultId 1